NCT Number: NCT03012126
Clinical & Community Approaches to Weight Management
This project seeks to build on innovative strategies to optimize the care of low-income children with a BMI ≥ 85th percentile. To accomplish this goal, investigators will implement a new clinical-community intervention, theoretically grounded in the Integrated Clinical and Community Systems of Care Model, to address obesity through optimized screening and management known to be effective, e-Referrals, Healthy Weight Clinics, and the YMCA's Healthy Weight and Your Child weight management program (originally known as MEND). The study will examine outcomes for children that matter most to a broad group of stakeholders including parents, clinicians, and public health practitioners as well as inform the care of >7 million children with obesity covered by the Children's Health Insurance Program or Medicaid.
Looking for future studies?
Notify MeKey information
Conditions
Age range
6 year–12 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
About this study
This is a 2-arm RCT. Enrolled patients are randomized to a pediatric weight management intervention (PWMI): 1)a Healthy Weight Clinic based at a federally-qualified health center (FQHC), or 2) a modified Healthy Weight and Your Child intervention delivered in YMCAs. A comparison sample of children receiving care in eight demographically similar FQHCs serve as a comparison group.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- child is age 6.0 through 12.9 years at referral
- child's BMI meets or exceeds the 85th percentile for age and sex
- parent can read and respond to interviews and questionnaires in English and Spanish
Exclusion criteria
- children who do not have at least one parent who is able to follow study procedures for 1 year
- families who plan to leave their primary care health center within the study time frame
- families for whom the primary care clinician thinks the intervention is inappropriate, e.g., emotional or cognitive difficulties
- children who were taking medications that substantially interfere with growth
- children who have a sibling enrolled in the study.
Treatment and study plan
Healthy Weight and Your Child
BehavioralPrimary outcomes
-
Change in Child BMI at 12 months
Time frame: 0-12 months
-
Change in Child BMI percent of the 95th percentile at 12 months
Time frame: 0-12 months
Secondary outcomes
-
Change in Screen Time at 12 months
Time frame: 0-12 months
Average hours per day of screen time as reported by parent
-
Change in Sleep Duration at 12 months
Time frame: 0-12 months
Average hours per day of sleep as reported by parent
-
Change in Physical Activity at 12 months
Time frame: 0-12 months
Average number of days (0-7) child is physically active for at least 60 minutes as reported by parent
-
Change in Diet at 12 months
Time frame: 0-12 months
Average daily intake of sugar-sweetened beverages and weekly intake of fast food as reported by parent
Sponsors and collaborators
Lead sponsor
Massachusetts General Hospital
Other
Collaborators
- Harvard School of Public Health (HSPH)
- Massachusetts Department of Health
- Y-USA
- Yale University
Registry information
Official study title
Childhood Obesity Research Demonstration Project 2.0 (CORD 2.0)
Acronym: CORD 2
Important dates
- Study start
- 2016
- Primary completion
- 2019
- Study completion
- 2019
- First posted
- Jan 6, 2017
- Registry last updated
- Feb 8, 2021
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Dietary Treatment Study of Fat Synthesis and Risk of Cardiovascular Disease
NCT02075710
Body Weight, Nutrition Disorders
San Francisco, California, United States
View Trial DetailsA Trial to Assess Bioavailability of AMG 133 in Participants With Overweight or Obesity
NCT07717814
Body Weight, Nutrition Disorders
Anaheim, California, United States
View Trial DetailsA Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous Presentations
NCT07313761
Body Weight, Nutrition Disorders
Anaheim, California, United States
View Trial DetailsCut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study
NCT05330247
Body Weight, Diabetes Mellitus
Copenhagen, Copenhagen NV, Denmark
View Trial Details